Piper Sandler Increases Aspen Aerogels (NYSE:ASPN) Price Target to $30.00

Aspen Aerogels (NYSE:ASPN - Free Report) had its price objective upped by Piper Sandler from $29.00 to $30.00 in a report issued on Tuesday, Benzinga reports. They currently have an overweight rating on the construction company's stock.

Several other equities research analysts have also recently weighed in on the company. Canaccord Genuity Group increased their price objective on Aspen Aerogels from $18.00 to $28.00 and gave the stock a buy rating in a report on Friday, May 3rd. HC Wainwright increased their price objective on shares of Aspen Aerogels from $20.00 to $25.00 and gave the stock a buy rating in a research report on Friday, May 3rd. Roth Mkm reiterated a buy rating and issued a $22.00 price target on shares of Aspen Aerogels in a report on Tuesday, April 30th. TheStreet upgraded shares of Aspen Aerogels from a d+ rating to a c- rating in a report on Wednesday, March 6th. Finally, B. Riley raised their price objective on Aspen Aerogels from $24.00 to $30.00 and gave the company a buy rating in a report on Friday, May 3rd. One research analyst has rated the stock with a sell rating and six have issued a buy rating to the stock. According to data from MarketBeat.com, Aspen Aerogels has an average rating of Moderate Buy and an average target price of $25.33.

Aspen Aerogels Price Performance

NYSE:ASPN traded down $1.92 during trading hours on Tuesday, hitting $25.41. The company's stock had a trading volume of 1,954,048 shares, compared to its average volume of 1,125,429. The company has a debt-to-equity ratio of 0.24, a current ratio of 4.01 and a quick ratio of 3.29. Aspen Aerogels has a twelve month low of $5.32 and a twelve month high of $27.91. The company has a market capitalization of $1.94 billion, a P/E ratio of -57.75 and a beta of 1.97. The stock has a fifty day simple moving average of $18.04 and a 200-day simple moving average of $14.71.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last posted its quarterly earnings results on Tuesday, February 13th. The construction company reported ($0.01) earnings per share for the quarter, beating the consensus estimate of ($0.12) by $0.11. Aspen Aerogels had a negative net margin of 10.73% and a negative return on equity of 6.35%. The firm had revenue of $84.22 million during the quarter, compared to the consensus estimate of $83.82 million. During the same period in the previous year, the firm posted ($0.20) earnings per share. On average, analysts anticipate that Aspen Aerogels will post 0.08 EPS for the current fiscal year.

Insider Transactions at Aspen Aerogels

In other Aspen Aerogels news, SVP Corby C. Whitaker sold 55,159 shares of the firm's stock in a transaction that occurred on Monday, May 6th. The shares were sold at an average price of $25.01, for a total value of $1,379,526.59. Following the sale, the senior vice president now owns 131,533 shares in the company, valued at $3,289,640.33. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other news, SVP Keith L. Schilling sold 20,000 shares of the stock in a transaction that occurred on Monday, May 13th. The shares were sold at an average price of $26.84, for a total value of $536,800.00. Following the completion of the sale, the senior vice president now directly owns 28,792 shares of the company's stock, valued at $772,777.28. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Corby C. Whitaker sold 55,159 shares of Aspen Aerogels stock in a transaction on Monday, May 6th. The shares were sold at an average price of $25.01, for a total value of $1,379,526.59. Following the sale, the senior vice president now directly owns 131,533 shares of the company's stock, valued at approximately $3,289,640.33. The disclosure for this sale can be found here. Corporate insiders own 4.30% of the company's stock.

Institutional Investors Weigh In On Aspen Aerogels

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Banque Cantonale Vaudoise increased its stake in Aspen Aerogels by 37.5% during the first quarter. Banque Cantonale Vaudoise now owns 4,593 shares of the construction company's stock valued at $81,000 after acquiring an additional 1,252 shares during the period. McAdam LLC acquired a new position in Aspen Aerogels in the fourth quarter worth about $191,000. Mirae Asset Global Investments Co. Ltd. grew its stake in shares of Aspen Aerogels by 71.4% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 23,052 shares of the construction company's stock valued at $198,000 after purchasing an additional 9,601 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank grew its position in Aspen Aerogels by 38.5% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 12,971 shares of the construction company's stock valued at $205,000 after acquiring an additional 3,607 shares during the period. Finally, Cornerstone Investment Partners LLC acquired a new position in Aspen Aerogels during the fourth quarter worth $230,000. 97.64% of the stock is owned by institutional investors and hedge funds.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.